4th iPSC Drug Development and Manufacturing Summit
Evvnt Promotion / evvnt
Archive
01.10.2024 - 03.10.2024 The Colonnade Hotel, 120 Huntington Avenue, 02116 Boston, Massachusetts, USA
Time: 08:00 - 17:00
Conference themes
With Kenai Therapeutics emerging from stealth with an $82 Million Series A funding round, 2024 has started strong for iPSC drug developers looking to showcase the potential of their pipelines ahead of the next wave of investment.
With Kenai Therapeutics emerging from stealth with an $82 Million Series A funding round, 2024 has started strong for iPSC drug developers looking to showcase the potential of their pipelines ahead of the next wave of investment.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Notes
Brochure: https://go.evvnt.com/2453698-3?pid=4832
Speakers: Allen Feng, Founder & Chief Scientific Officer, HebeCell, Anne Plant, Fellow Chief, Biosystems and Biomaterials Division, National Institute of Standards & Technology (NIST), and more
Brochure: https://go.evvnt.com/2453698-3?pid=4832
Speakers: Allen Feng, Founder & Chief Scientific Officer, HebeCell, Anne Plant, Fellow Chief, Biosystems and Biomaterials Division, National Institute of Standards & Technology (NIST), and more
Enquiries and Registration:
https://go.evvnt.com/2453698-2?pid=4832
Ms. Lara Chick
General Medicine
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International promotes access to education and training for all regardless of social, geographic and national borders."
